Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Growth Projections For The Pulmonary Drug Delivery Devices Market Size During 2025–2029?
Strong upward momentum has characterized the pulmonary drug delivery devices market recently, projecting an expansion from a valuation of $49.52 billion in 2024 to reach $52.8 billion by 2025, reflecting a compound annual growth rate (CAGR) of 6.6%. This growth trajectory during the past period is fundamentally linked to several key factors: the escalating incidence of respiratory ailments, notably COPD, asthma, and cystic fibrosis; a global demographic shift toward an older population; heightened consciousness regarding respiratory wellness; augmented spending on healthcare within developing nations; and a greater utilization of home-based environments for ongoing respiratory treatments.
Anticipated in the forthcoming years is a robust expansion for the pulmonary medication administration devices sector, projected to reach a valuation of $68.18 billion by 2029, demonstrating a steady compound annual growth rate (CAGR) of 6.6%; this upward trajectory through the forecast span is underpinned by several factors, notably the escalating need for tailored and exact medicine in treating respiratory ailments, the broadening scope of domiciliary care options alongside remote patient observation, increased financial commitments toward scientific research and development efforts, and a heightened emphasis on proactive health maintenance and timely remedial actions.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15907&type=smp
What Are The Top Growth Drivers Impacting The Pulmonary Drug Delivery Devices Market Outlook?
The mounting frequency of ailments affecting respiration is anticipated to be a key driver fueling the expansion of the market for pulmonary therapeutic delivery apparatuses. These conditions, which compromise lung and airway function essential for breathing, are becoming more common due to various converging elements, including heightened air contamination, greater tobacco usage, denser urban living, shifts in global weather patterns, and demographic aging. Because they permit medications to be administered straight into the pulmonary system, inhalation delivery technologies are crucial in managing these respiratory illnesses. As an illustration, data from the US national public health entity, the Centers for Disease Control And Prevention (CDC), revealed in May 2024 that the incidence of active asthma among US adults aged 18 and above rose from 8.0% in 2021 to 8.7% in 2022, underscoring the trend that points toward sustained growth for the pulmonary drug delivery market.
What Are The Emerging Segments Gaining Attention In The Pulmonary Drug Delivery Devices Market?
The pulmonary drug delivery devicesmarket covered in this report is segmented –
1) By Product Type: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Application: Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-Commerce
Subsegments:
1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs
2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs, HFA-Based MDIs
3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers
Which Key Trends Are Expected To Influence The Pulmonary Drug Delivery Devices Market In The Coming Years?
Leading entities within the marketplace for pulmonary drug delivery apparatus are bringing forth novel merchandise, notably small-volume nebulizers, with the goal of providing enhanced customer service through superior functionalities. Functioning as a healthcare tool for respiratory ailments like asthma, chronic obstructive pulmonary disease, or cystic fibrosis, the small-volume nebulizer (SVN) converts prescribed liquid pharmaceuticals into a fine, breathable aerosol mist for patient inhalation. A pertinent illustration involves Medline Industries LP, an American healthcare firm, which introduced its Hudson RCI TurboMist small-volume nebulizer during May 2024. This state-of-the-art apparatus has been engineered to administer therapeutic agents swiftly, often completing a full cycle in only three minutes. The inventive nebulizer possesses the capability to dispense medication at a rate that is 2.5 times greater per minute when contrasted with conventional nebulizers, thus resulting in treatment durations that are approximately 70% shorter. This marked escalation in the rate at which medication is delivered substantially slashes the time required for treatment, providing advantages to medical professionals by making patient flow more efficient and improving the patient journey by minimizing therapy session lengths.
Who Are The Prominent Global Companies Shaping The Pulmonary Drug Delivery Devices Market?
Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Currently Holds The Largest Share Of The Pulmonary Drug Delivery Devices Market?
North America was the largest region in the pulmonary drug delivery devices market in 2024. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Pulmonary Drug Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15907&type=smp
Browse Through More Reports Similar to the Global Pulmonary Drug Delivery Devices Market 2025, By The Business Research Company
Pulmonary Embolism Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report
Pulmonary Arterial Hypertension Global Market Report 2025
Chronic Obstructive Pulmonary Disease Copd Treatment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model